LCAR-F33S in Treatment of Relapsed/Refractory Multiple Myeloma
Clinical trial NCT07100067 · RECRUITING
Trial details
- NCT number
- NCT07100067
- Sponsor
- Nanjing Legend Biotech Co.
- Status
- RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2025-09-16
- Primary completion
- 2028-02-20
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.